በኮሎራዶ ለMigraine የሚደረጉ ክሊኒካዊ ጥናቶች
ለMigraine የሚደረጉ 7 ጥናቶች በኮሎራዶ ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በኮሎራዶ ውስጥ ያሉ ከተሞች
Official study text (English)
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Children's Hospital Colorado- Investigational Drug Services, Aurora
- Children's Hospital Colorado, Aurora
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ6 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Children's Hospital Colorado- lnvestigational Drug Services, Aurora
- Children's Hospital Colorado, Aurora
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ6 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT04649242Puberty, Testosterone, and Brain Development
- Children's Hospital Colorado, Aurora
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ12 እስከ 20 · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT06670053Responding With Evidence and Access for Childhood Headaches
- University of Colorado/Children's Hospital Colorado, Aurora
ተሳታዮችን በመፈለግ ላይ
እድሜ ከ10 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT05889624Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- University of Colorado Anschutz Medical Campus, Aurora
ተሳታዮችን በመፈለግ ላይደረጃ 4
እድሜ ከ18 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ16 ሴፕቴ 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Paradigm Clinical Research - Aurora, CO /ID# 280612, Aurora
- Children's Hospital Colorado - Aurora /ID# 231879, Aurora
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ6 እስከ 17 · ሁሉም ጾታዎች · የተሻሻለው በ14 ሴፕቴ 2026 · NCT05125302A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- IMMUNOe Research Centers, Centennial
- MCB Clinical Research Centers, Colorado Springs
- Advanced Neurosciences Research, Fort Collins
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ ከ18 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ20 ኦገስ 2026 · NCT07645924ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።